File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ccell.2023.01.003
- Scopus: eid_2-s2.0-85147560106
- PMID: 36736318
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment
Title | IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment |
---|---|
Authors | Leca, JulieLemonnier, FranҫoisMeydan, CemFoox, JonathanEl Ghamrasni, SamahMboumba, Diana LaureDuncan, Gordon S.Fortin, JeromeSakamoto, TakashiTobin, ChantalHodgson, KelseyHaight, JillianSmith, Logan K.Elia, Andrew J.Butler, DanielBerger, Thorstende Leval, LaurenceMason, Christopher E.Melnick, AriGaulard, PhilippeMak, Tak W. |
Keywords | Angioimmunoblastic T cell lymphoma cytokines epigenetics germinal center B cells Idh2 preclinical mouse model T follicular helper cells Tet2 therapeutic agents tumor microenvironment |
Issue Date | 13-Feb-2023 |
Publisher | Cell Press |
Citation | Cancer Cell, 2023, v. 41, n. 2, p. 323-339.e10 How to Cite? |
Abstract | Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma that originates from T follicular helper (Tfh) cells and exhibits a prominent tumor microenvironment (TME). IDH2 and TET2 mutations co-occur frequently in AITL, but their contribution to tumorigenesis is poorly understood. We developed an AITL mouse model that is driven by Idh2 and Tet2 mutations. Malignant Tfh cells display aberrant transcriptomic and epigenetic programs that impair TCR signaling. Neoplastic Tfh cells bearing combined Idh2 and Tet2 mutations show altered cross-talk with germinal center B cells that promotes B cell clonal expansion while decreasing Fas-FasL interaction and reducing B cell apoptosis. The plasma cell count and angiogenesis are also increased in the Idh2-mutated tumors, implying a major relationship between Idh2 mutation and the characteristic AITL TME. Our mouse model recapitulates several features of human IDH2-mutated AITL and provides a rationale for exploring therapeutic targeting of Tfh-TME cross-talk for AITL patients. |
Persistent Identifier | http://hdl.handle.net/10722/354654 |
ISSN | 2023 Impact Factor: 48.8 2023 SCImago Journal Rankings: 17.507 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leca, Julie | - |
dc.contributor.author | Lemonnier, Franҫois | - |
dc.contributor.author | Meydan, Cem | - |
dc.contributor.author | Foox, Jonathan | - |
dc.contributor.author | El Ghamrasni, Samah | - |
dc.contributor.author | Mboumba, Diana Laure | - |
dc.contributor.author | Duncan, Gordon S. | - |
dc.contributor.author | Fortin, Jerome | - |
dc.contributor.author | Sakamoto, Takashi | - |
dc.contributor.author | Tobin, Chantal | - |
dc.contributor.author | Hodgson, Kelsey | - |
dc.contributor.author | Haight, Jillian | - |
dc.contributor.author | Smith, Logan K. | - |
dc.contributor.author | Elia, Andrew J. | - |
dc.contributor.author | Butler, Daniel | - |
dc.contributor.author | Berger, Thorsten | - |
dc.contributor.author | de Leval, Laurence | - |
dc.contributor.author | Mason, Christopher E. | - |
dc.contributor.author | Melnick, Ari | - |
dc.contributor.author | Gaulard, Philippe | - |
dc.contributor.author | Mak, Tak W. | - |
dc.date.accessioned | 2025-03-02T00:35:10Z | - |
dc.date.available | 2025-03-02T00:35:10Z | - |
dc.date.issued | 2023-02-13 | - |
dc.identifier.citation | Cancer Cell, 2023, v. 41, n. 2, p. 323-339.e10 | - |
dc.identifier.issn | 1535-6108 | - |
dc.identifier.uri | http://hdl.handle.net/10722/354654 | - |
dc.description.abstract | Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma that originates from T follicular helper (Tfh) cells and exhibits a prominent tumor microenvironment (TME). IDH2 and TET2 mutations co-occur frequently in AITL, but their contribution to tumorigenesis is poorly understood. We developed an AITL mouse model that is driven by Idh2 and Tet2 mutations. Malignant Tfh cells display aberrant transcriptomic and epigenetic programs that impair TCR signaling. Neoplastic Tfh cells bearing combined Idh2 and Tet2 mutations show altered cross-talk with germinal center B cells that promotes B cell clonal expansion while decreasing Fas-FasL interaction and reducing B cell apoptosis. The plasma cell count and angiogenesis are also increased in the Idh2-mutated tumors, implying a major relationship between Idh2 mutation and the characteristic AITL TME. Our mouse model recapitulates several features of human IDH2-mutated AITL and provides a rationale for exploring therapeutic targeting of Tfh-TME cross-talk for AITL patients. | - |
dc.language | eng | - |
dc.publisher | Cell Press | - |
dc.relation.ispartof | Cancer Cell | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Angioimmunoblastic T cell lymphoma | - |
dc.subject | cytokines | - |
dc.subject | epigenetics | - |
dc.subject | germinal center B cells | - |
dc.subject | Idh2 | - |
dc.subject | preclinical mouse model | - |
dc.subject | T follicular helper cells | - |
dc.subject | Tet2 | - |
dc.subject | therapeutic agents | - |
dc.subject | tumor microenvironment | - |
dc.title | IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ccell.2023.01.003 | - |
dc.identifier.pmid | 36736318 | - |
dc.identifier.scopus | eid_2-s2.0-85147560106 | - |
dc.identifier.volume | 41 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 323 | - |
dc.identifier.epage | 339.e10 | - |
dc.identifier.eissn | 1878-3686 | - |
dc.identifier.issnl | 1535-6108 | - |